IHH Healthcare core profit up 3% in 2025 as revenue hits $6.6b

Core revenue rose 18%.

IHH Healthcare’s profit after tax and minority interests (PATMI), excluding exceptional items, increased 3% to $581m (RM2.3b) for the financial year (FY) ended 31 December 2025, according to its financial report.

Core revenue rose 18% year on year to $6.62b (RM26.2b), whilst earnings before interest, taxes, depreciation, and amortisation increased 14% to $1.46b (RM5.8b).

The board declared a final dividend of $0.014 (5.5 sen) per share, whilst total ordinary dividends for FY2025 reached $0.027 (10.5 sen) per share, up from $0.025 (10.0 sen) in FY 2024.

The payout ratio exceeded 40% of PATMI, above the group’s minimum policy of 30%.

Return on equity (ROE), excluding exceptional items and MFRS129 effects, stood at about 9% for FY2025, with the group maintaining its target of double-digit ROE by 2028.

(US$1 = RM3.96)

Follow the link for more news on

IHH Healthcare

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia